. Author manuscript; available in PMC: 2011 Jul 28.

Published in final edited form as: Clin Toxicol (Phila). 2009 May;47(5):407–411. doi: 10.1080/15563650902915320

Table 1.

symptoms, signs and biochemistry of prospective admissions

	KMNO₄+ Oxalic acid N=51		KMNO₄ N=13	Oxalic acid N=51
Ingested Amount^*	KMNO₄1.2g (IQR 1.2- 2.4)	OA 12.5g (IQR 12.5-25).	1.2g (1.2- 12.2)	12.5g (IQR 12.5- 12.5).
Age^*	24 (IQR 20-28)		19(16-34)	24(19-37.5)
Hospital Stay Days^*	4 (IQR 4-5)		4(IQR4-5)	4 (IQR 4-5).
Deaths and CFR (95%CI)	5, 9.8(3.2-21)		0	13, 25.4(14-39)
Epigastric pain nausea, vomiting (%)	95		73	60
Haematemesis (%)	10		0	16
Weakness and headache (%)	20		27	30
Serum creatinine^*	1.7(0.91-4.4)		NA	NA
SGPT^* (IU/L)	25.5(10-43.5)		NA	NA
Na^* (mmol/L)	135(130-144)		NA	NA
K^* (mmol/L)	4.1(3.8-4.2)		NA	NA
Laryngeal oedema	1		0	0
Skin burns	0		1	0

median and inter quartile range.; SGPT= serum glutamic pyruvic transferase; NA= not available; 95%CI= 95% confidence Interval